Multiple myeloma is a type of blood cancer that develops in plasma cells within the bone marrow, disrupting the production of healthy blood cells and weakening the immune system. This condition can cause various symptoms, such as bone pain, fatigue, recurrent infections, anemia, kidney problems, and elevated calcium levels in the blood. Because its symptoms often resemble other illnesses, accurate and timely medical evaluation is crucial for early detection of multiple myeloma.
At Mandaya Royal Hospital Puri, patients with multiple myeloma receive comprehensive treatment options tailored to their medical needs, ranging from chemotherapy and immunotherapy to targeted therapy and stem cell transplant. The hospital is supported by an experienced team of KHOM (Cancer, Hematology, and Medical Oncology) specialists trained in managing multiple myeloma cases using up-to-date, evidence-based medical practices.
Contents
Multiple Myeloma Treatment Options at Mandaya Royal Hospital Puri
Below are the multiple myeloma treatment options available at Mandaya Royal Hospital Puri:
1. Targeted therapy
Targeted therapy uses medications designed to attack specific chemicals or components within cancer cells. By blocking these targets, the treatment helps destroy cancer cells more effectively.
2. Immunotherapy
Immunotherapy works by using medications to enhance the body’s immune system so it can identify and destroy cancer cells. While the immune system naturally fights infections and abnormal cells, cancer cells can evade detection. Immunotherapy helps immune cells recognize and attack these cancer cells.
3. Chemotherapy
Chemotherapy uses powerful medications to kill cancer cells. These drugs target rapidly dividing cells, including myeloma cells.
4. Radiation therapy
Radiation therapy delivers high-energy beams, such as X-rays or protons, to kill cancer cells. This treatment can quickly shrink myeloma cell growth and is commonly used when multiple myeloma forms a mass called a plasmacytoma. It also helps manage pain or bone damage caused by plasmacytomas.
Multiple Myeloma Specialist Doctors at Mandaya Royal Hospital Puri
Mandaya Royal Hospital Puri is home to a team of highly experienced specialists who manage multiple myeloma and other blood cancers. These experts are trained in Hematology–Medical Oncology (KHOM) and have completed extensive education and clinical training both in Indonesia and abroad. Below are brief profiles of the doctors involved in multiple myeloma care at Mandaya Royal Hospital Puri:
1. Dr. Toman T.J Lumban Toruan, Sp.PD-KHOM
Dr. Toman is an internist specializing in Hematology–Medical Oncology. He completed his general medical and subspecialty training at the University of Indonesia and pursued an Honorary Fellowship at the Department of Hematology, National University Hospital, Singapore.
He is experienced in treating multiple myeloma using chemotherapy, immunotherapy, targeted therapy, and apheresis.
Practice schedule:
- Tuesday: 12.00 – 15.00 WIB
- Thursday: 12.00 – 15.00 WIB
2. Dr. Alvin Tagor Harahap, Sp.PD-KHOM
Dr. Alvin is an internist with a subspecialty in Hematology–Medical Oncology from the University of Indonesia. He manages complex blood cancer cases, including multiple myeloma, and provides comprehensive treatments such as chemotherapy, immunotherapy, targeted therapy, and apheresis.
Practice schedule:
- Wednesday: 18.00 – 20.00 WIB
- Saturday: 10.00 – 12.00 WIB
3. Prof. DR. Aru W. Sudoyo, Sp.PD-KHOM, FINASIM, FACP
Prof. Aru is one of Indonesia’s leading experts in hematology–oncology. He completed his specialist, consultant, and doctoral training at the University of Indonesia and has extensive experience in managing multiple myeloma and other blood cancers.
He is skilled in advanced treatments, including chemotherapy, immunotherapy, targeted therapy, stem cell transplant, and CAR-T cell therapy.
Practice schedule:
- Wednesday: 08.00 – 12.00 WIB
4. Dr. dr. Andree Kurniawan, Sp.PD-KHOM, FINASIM
Dr. Andree is an internist specializing in Hematology–Medical Oncology. He treats multiple myeloma using a personalized approach with therapies such as chemotherapy, immunotherapy, and targeted therapy, ensuring that each patient receives the most suitable care.
Practice schedule:
- Monday: 17.00 – 19.00 WIB
- Thursday: 17.00 – 19.00 WIB
5. Dr. Nia Noviantri Siregar, Sp.PD, Subsp.H-Onk.M (K)
Dr. Nia is a consultant in Hematology–Medical Oncology with extensive experience managing multiple myeloma and other complex hematologic disorders. She is skilled in chemotherapy, immunotherapy, and targeted therapy and is committed to providing individualized and up-to-date cancer care.
Practice schedule:
- Tuesday: 17.00 – 20.00 WIB
- Friday: 17.00 – 20.00 WIB
Mandaya Blood Cancer Center Partners with NCIS-NUH Singapore
The Mandaya Blood Cancer Center collaborates closely with the National University Cancer Institute (NCIS-NUH) Singapore. Every blood cancer case treated at Mandaya Royal Hospital Puri undergoes joint review and discussion with experts from NCIS-NUH as part of a comprehensive medical assessment.
This collaboration provides significant benefits for patients, ensuring more accurate and personalized treatment recommendations. From establishing the diagnosis, evaluating treatment response, to selecting the most appropriate therapy, all processes follow international standards—resulting in safer, more precise, and optimal care.
To simplify your visit to Mandaya Royal Hospital Puri and consult with our KHOM specialists, utilize our WhatsApp Chat feature, Book Appointment service, or the Care Dokter app—available on Google Play and the App Store—to check queue numbers, book visits, and access complete information.
